Login

Journal Image
Recent Patents on Cardiovascular Drug Discovery
ISSN (Print): 1574-8901
ISSN (Online): 2212-3962
VOLUME: 8
ISSUE: 3
DOI: 10.2174/1574890109666140407154738      Price:  $100









Novel Antidepressant Drugs, Arterial Hypertension and Cardiovascular Disease

img
Author(s): Vasiliki K. Katsi, Maria Marketou, Georgia Vamvakou, Thomas Makris, Dimitris Tousoulis, Christodoulos I. Stefanadis, Panos Vardas and Ioannis E. Kallikazaros
Pages 178-185 (8)
Abstract:
Depression is a common mental health issue worldwide leading to disability, functional decline and increased mortality. Novel antidepressants have been developed during the last decades in order to treat depression syndromes. Some evidence suggests that major depression has been associated with the development of congestive heart failure and with adverse outcomes in patients with coronary heart disease. The purpose of the present article is to review the impact of novel antidepressant patent drugs on cardiovascular disease and arterial hypertension.
Keywords:
Arterial hypertension, bupropion, cardiovascular disease, depression, fluoxetine, norepinephrine reuptake inhibitors, serotonin reuptake inhibitors.
Affiliation:
Cardiology Department, Hippokration Hospital, Greece, Vas. Sofias Avenue 114, Post code: 11527, Athens, Greece.